BLINCYTO 38.5 micrograms powder for concentrate and solution for solution for infusion

Active Ingredient
Strength
  • Blinatumomab: 12.5 µg
Dosage Form
Pdr/Conc/Soln for Infusion
Legal Category
A - prescription, may not be renewed
Last Updated
25/09/2026
SPC section shown.

Loading the document

Amgen Ireland Ltd

21 Northwood Court, Santry, Dublin D09 TX31, Ireland 216 Cambridge Science Park, Milton Road, Cambridge, Cambridgeshire, CB4 0WA, UK

Telephone
+441223436441